Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I

Endocrinology

Volumn 148, Issue 5, 2007, Pages 2435-2443

  Maile, Laura A ^a,b   Capps, Byron E ^a   Ling, Yan ^a   Xi, Gang ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPONTIN; PROTEIN SHC; SCLEROPROTEIN; SOMATOMEDIN C; THROMBOSPONDIN; VITRONECTIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOTHESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; ANIMAL; AORTA; CELL DIVISION; CELL MOTION; CHO CELL; CRICETULUS; CYTOLOGY; DRUG EFFECT; HAMSTER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SWINE; VASCULAR SMOOTH MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AORTA; CELL DIVISION; CELL MOVEMENT; CHO CELLS; CRICETINAE; CRICETULUS; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHAVBETA3; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; THROMBOSPONDINS; VITRONECTIN;

EID: 34249794018     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1440     Document Type: Article

References (46)

1. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL 1999 Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6:347-363
2. Russell JW, Golovoy D, Vincent AM, Mahendra P, Olzmann JA, Mentzer A, Feldman EL 2002 High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16:1738-1748
3. Mishra R, Emancipator SN, Kern T, Simonson MS 2005 High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int 67:82-93
4. Kang BP, Frencher S, Reddy V, Kessler A, Malhotra A, Meggs LG 2003 High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am J Physiol Renal Physiol 284:F455-F466
5. Sheu ML, Ho FM, Yang RS, Chao KF, Lin WW, Lin-Shiau SY, Liu SH 2005 High glucose induces human endothelial cell apoptosis through a phospho-inositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 25:539-545
6. Peiro C, Lafuente N, Matesanz N, Cercas E, Llergo JL, Vallejo S, Rodriguez-Manas L, Sanchez-Ferrer CF 2001 High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 133:967-974
7. Li H, Telemaque S, Miller RE, Marsh JD 2005 High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 54:540-545
8. Campbell M, Allen WE, Silversides JA, Trimble ER 2003 Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-β receptor potentiates vascular smooth muscle cell chemotaxis. Diabetes 52:519-526
9. Campbell M, Allen WE, Sawyer C, Vanhaesebroeck B, Trimble ER 2004 Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res 95:380-388
10. Jones JI, Prevette T, Gockerman A, Clemmons DR 1996 Ligand occupancy of the α-V-β3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487
11. Ling Y, Maile LA, Lieskovska J, Badley-Clarke J, Clemmons DR 2005 Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Mol Biol Cell 16:3353-3364
12. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Ling Y, Clemmons DR 2006 The heparin-binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol 20:881-892
13. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons, DR 2006 IGF-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the β3 subunit of αVβ3. Mol Endocrinol 20:405-413
14. Xin X, Khan ZA, Chen S, Chakrabarti S 2004 Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 84:1451-1459
15. Xin X, Khan ZA, Chen S, Chakrabarti S 2005 Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells. Diabetologia 48:2428-2436
16. Kawamura H, Yokote K, Asaumi S, Kobayashi K, Fujimoto M, Maezawa Y, Saito Y, Mori J 2004 High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 24:276-281
17. Ross R 1971 The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172-186
18. Zheng B, Clemmons DR 1998 Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:11217-11222
19. Maile LA, Clemmons DR 2003 Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ Res 93:925-931
20. Ross R, Wight TN, Strandness E, Thiele B 1984 Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 114:79-93
21. Zheng B, Duan C, Clemmons DR 1998 The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem 273:8994-9000
22. Campbell GR, Campbell JH 1990 The phenotypes of smooth muscle expressed in human atheroma. Ann NY Acad Sci 598:143-158
23. Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J 1988 Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 107:307-319
24. Hedin U, Sjolund M, Hultgardh-Nilsson A, Thyberg J 1990 Changes in expression and organization of smooth-muscle-specific α-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. Differentiation 44:222-231
25. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA 1990 Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966-990
26. Imai Y, Clemmons DR 1999 Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyribonucleic acid synthesis by insulin-like growth factor-I. Endocrinology 140:4228-4235
27. Ling Y, Maile LA, Clemmons DR 2003 Tyrosine phosphorylation of the β3-subunit of the αVβ3 integrin is required for membrane association of the tyrosine phosphatase SHP-2 and its further recruitment to the insulin-like growth factor I receptor. Mol Endocrinol 17:1824-1833
28. Holmes DIR, Wahab NA, MasonRM1997 Identification of glucose-regulated genes in human mesangial cells by mRNA differential display. Biochem Biophys Res Commun 238:179-184
29. Sheibani N, Sorenson CM, Cornelius LA, Frazier WA 2000 Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun 267:257-261
30. Wang S, Skorczewski J, Feng X, Mei L, Murphy-Ullrich JE 2004 Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-β activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279:34311-34322
31. Stenina OI, Krukovets I, Wang K, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, Plow EF 2003 Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation 107:3209-3215
32. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, Tamura K, Saito Y, Mori S 2000 Enhanced expression of osteopontin by high glucose: involvement of osteopontin in diabetic macroangiopathy. Ann NY Acad Sci 902:357-363
33. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, Tamura K, Saito Y, Mori S 1999 Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 258:722-726
34. Yoon S, Gingras D, Bendayan M 2001 Alterations of vitronectin and its receptor α(v) integrin in the rat renal glomerular wall during diabetes. Am J Kidney Dis 38:1298-1306
35. Goldin A, Beckman JA, Schmidt AM, Creager MA 2006 Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597-605
36. Yang YL, Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Huang YL 2004 Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin. Biochem J 379:89-97
37. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM 1994 Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490
38. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H 1999 Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 258:353-357
39. Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT 1996 Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 75:325-338
40. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
41. Hedin U, Bottger BA, Luthman J, Johansson S, Thyberg J 1989 A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev Biol 133:489-501
42. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, Sobue K 1998 Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273:28860-28867
43. Hayashi K, Shibata K, Morita T, Iwasaki K, Watanabe M, Sobue K 2004 Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J Biol Chem 279:40807-40818
44. Dilley RJ, Schwartz SM 1989 Vascular remodeling in the growth hormone transgenic mouse. Circ Res 65:1233-1240
45. Zhu B, Zhao G, Witte DP, Hui DY, Fagin JA 2001 Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142:3598-3606
46. Gonzalez B, Lamas S, Melian EM 2001 Cooperation between low density lipoproteins and IGF-I in the promotion of mitogenesis in vascular smooth muscle cells. Endocrinology 142:4852-4860